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1. Introduction 
Soybeans (Glycine max [L.] Merr.) contain an impressive array of biologically active 
components. People have been eating soybeans for almost 5,000 years. Unlike most plant 
foods, soybeans are high in protein. Researchers are interested in both the nutritional value 
and the potential health benefits of soybeans. Research of the health effects of soyfoods and 
soybean constituents has been received significant attention to support the health 
improvements or health risks observed clinically or in vitro experiments. This research 
includes a wide range of areas, such as cancer, coronary heart disease (cardiovascular 
disease), osteoporosis, cognitive function (memory related), menopausal symptoms, renal 
function, and many others. This chapter provides up-to-date coverage on biologically active 
and related organic molecules isolated from soy and soy products. Their biological activities 
are briefly summarized. Molecules discussed in this chapter are as follows: isoflavones, 
phytic acid, soy lipids, soy phytoalexins, soyasaponins, lectins, hemagglutinin, soy toxins, 
and vitamins.  
2. Health benefit of soy or soy products 
Soy products have been considered as great source of protein for many decades. Japanese, in 
particular, eat a soy-based diet. Japanese monks eat soy products as their main protein 
source. They are known to live longer and have lower rates of chronic diseases. Because 
soybeans contain practically no starch, soybeans are an important part of a diabetic diet. 
Soybeans are 1) rich in protein (vide supra), calcium, and vitamins, and 2) high in mono-
saturated fatty acids. In addition, soybeans contain several biologically interesting 
phytochemicals as minor components, which scientists are interested in understanding their 
biological functions.  
Many studies have shown that American and European males have a ten-fold increase in 
the risk of prostate cancer development as compared with East Asian countries. The 
observed difference prevalence of prostate cancers is considered due, in part, to difference in 
soy consumption. Some studies indicated that isoflavones found in soybeans contribute to 
the risk reduction of prostate cancer. Although there is a lack of unequivocal evidences that 
consuming soy as an adult may reduce the risk of breast cancer, several researches have 
reported that consuming soy products as a teenager may help reduce breast cancer risk as 
an adult. Some medical research has determined that ingredients of soybeans may help 
reduce the risk of colon cancer and heart diseases. The dramatic increase in soy products is 
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due largely to the fact that the US FDA approved soy products as an official cholesterol-
lowering food, along with other heart and health benefits due to the evidence that soy 
product intake is correlated with significant decreases in serum cholesterol, low-density 
lipoprotein (LDL, bad cholesterol) and triglycerides. Although a significant health benefit 
has been observed in people with a high soy intake (vide supra), some scientists have argued 
that reported health benefits are poorly supported by the available experimental evidences. 
It seems to be difficult to support soy product benefit by in vitro studies using individually 
isolated phytochemicals (a wide variety of compounds produced by plants) or crude 
products prepared from soy. It is important to note that all phytochemicals isolated from 
soybeans show an array of weak biological activities, thus, normal consumption of foods 
that contain these phytochemicals should not provide sufficient amounts to elicit a visible 
physiological response in humans in short-time clinical researches.  
3. Chemical composition of soybeans 
Remarkably, seeds of soy contain very high levels of protein, carbohydrate conjugates, fatty 
acids (soybean oil), amino acids, and inorganic materials (minerals). Among these soybean 
components, protein and fatty acid content account for about 40% and 20%, respectively. 
The remaining components consist of carbohydrate conjugates, inorganic constituents, and 
the minor components of biologically interesting small molecules (molecules highlighted 
below). Thus, soybeans constitute important nutritional components. Soybeans are 
considered to be a good substituents of protein (essential amino acids), amongst other major 
vegetables, for animal products. This chapter reviews secondary metabolites isolated from 
soy and soy products that show interesting biological activities.  
3.1 Isoflavones 
Isoflavones (a subgroup of flavonoids) are known to be highly potent antioxidants (Fig.1). 
As stated above, the consumption of soy products has many health benefits, including 
protection against breast cancer, prostate cancer, menopausal symptoms, heart disease and 
osteoporosis. Many of the health benefits of soy are derived from its isoflavones. Isoflavones 
are produced via a branch of the general phenylpropanoid pathway biosynthesis (begins 
from phenylalanine) that produces flavonoid compounds in legumes and stored as glucosyl- 
and malonyl-glucose conjugates (Graham, 1991). The major isoflavones in soybean are 
genistein, daidzein, and glycitein, comprising about 50, 40, and 10% of total isoflavone 
profiles, respectively. The chemical structure of isoflavones is similar to that of the primary 
female sex hormone, estrogen. Because of this similarity in structure, they can interfere with 
the action of estrogen. Thus, isoflavones are often called “phytoestrogens”. The common 
biological roles of phytoestrogens are to protect plants from stress and to act as part of a 
plant’s defence mechanism. Some scientists postulate that phytoestrogens may have evolved 
to protect the plants by interfering with the reproductive ability of grazing animals. The 
estrogen effects of isoflavones are much less effective than estrogen; its effectiveness 
represents around 1/1000 of estrogen. Isoflavones can also reduce the effect of the estrogen 
on cells and skin layers when the hormone levels are high, reducing the risk of estrogen 
linked cancers. There are two other classes (lignans and coumestans) of phytoestrogens that 
have estrogen-like actions in the human body. Isoflavones have been reported to show 
estrogenic, antifungal, anti-tumor and anti-mutagenic properties (Rishi, 2002; Dorge and 
Sheehan, 2002; Coward et al., 1993; Miyazawa, 1999). Isoflavones remain the subject of many 
scientific studies, as illustrated by the more than 18,000 scientific publications. 
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Fig. 1. Structures of soy isoflavones 
3.1.1 Genistein 
Genistein is found in a number of plants including soybeans, lupin, fava beans, kudzu, 
psoralea, and coffee. Genistein is the most discussed phytoestrogenic substance, because it is 
very well represented in soybeans. Genistein influences several targets in living cells. Due to 
its structural similarity to estrogen (i.e. 17ǃ-estradiol, Fig. 2), genistein can bind to estrogen 
receptors. Genistein shows much higher affinity toward estrogen receptor ǃ (ER) than 
toward estrogen receptor ǂ (ER).  
 
 
Fig. 2. Structures of estrogen 
Estrogen is a key regulator of growth and differentiation in a broad range of tissues, 
including the reproductive (genital) system, mammary gland, central nervous and skeletal 
systems. Estrogen is also known to be involved in breast and endometrial cancers. To date, 
two key conclusions can be highlighted from the significant number of studies on the 
specific roles of the two receptor subtypes in diverse estrogen target tissues. ER and ER 
have different transcriptional activities in certain cell-type, which help to explain some of 
the major differences in their tissue-specific biological actions. Both ERs are widely 
expressed in different tissue types, however, there are some distinct differences in their 
expression patters. The ER is found in the inner membrane of the uterus (endometrium) 
and breast cancer cells. On the other hand, ER is found in kidney, brain, bone, heart, lung, 
intestinal mucosa, prostate, and endothelial cells. Unwanted effects are generally mediated 
through ER. Roles of ER have been the subjects of interest in human cancer researches. 
Recent studies have shown that ER is lost in majority of breast tumors and thus ESR2 gene, 
encoding ER, is suggested to be a possible tumor suppressor gene. Similarly, ER 
overexpression in ovarian cancer cells is suggested to exert antitumoral effects. ER is highly 
expressed in prostate cancer cells, and is the predominant estrogen receptor in the colonic 
epithelium. Thus, effects of estrogen in these cells or tissues are mediated by ER. Therefore, 
non-steroidal ER-antagonist has potential to be a clinically useful drug. 
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In the 1960’s, many researches regarding the physiological effects of genistein were limited 
to its estrogenic activity. Genistein have also been shown to possess antifungal activities 
(Weidernbörner, et al. 1989), antiangiogenic effects (blocking formation of new blood 
vessels), and may block the uncontrolled cell growth associated with cancer, most likely by 
inhibiting the activity of substances in the body that regulate cell division and cell growth 
factors. Various studies have found moderate doses of genistein to have inhibitory effects on 
cancers of the prostate, cervical, brain, breast, and colon. Additionally it has been shown 
that genistein makes some cells more sensitive to radio-therapy. Genistein has shown a 
protein tyrosine kinase inhibitory activity. Tyrosine kinases are implicated in almost all cell 
growth and proliferation signal cascades. Genistatin’s inhibition of DNA topoisomerase II 
also plays an important role in the cytotoxic activity of genistein.  
3.1.2 Daidzein 
Daidzein is also present a number of plants. Soy foods typically contain more genistein than 
daidzein. Structurally, daidzein lacks the 5-hroxy group of genistein (Fig. 1). Genistein and 
daidzein can transfer across the human placenta at environmentally relevant levels and their 
influence to early puberty in children is unknown. In vitro and in vivo studies have shown 
that daidzein stimulates the growth of estrogen-sensitive breast cancer cells. Some 
epidemiological evidence indicates that soy intake may be more protective when the 
exposure occurs prior to puberty. More research needs to be conducted on the association 
between breast cancer risk and daidzein specifically before conclusions can be drawn. 
Daidzein is metabolized in the colon by bacteria to equol and another isoflavones. Daidzein 
is available as a dietary supplement.  
3.1.3 Glycitein 
Glycitein is unique in that it is an isoflavone found in soy with a methoxy group. 
Methylated isoflavones have been shown to be more bioavailable and biologically stable 
than non-methylated isoflavones. Glycitein accounts for 5-10% of the total isoflavones in soy 
food products. Glycitein shows a weak estrogenic activity, comparable to that of the other 
soy isoflavones.  
3.1.4 Formononetin 
Formononetin is an O-methylated isoflavone. It is found in the family Fabaceae and 
Ranunculaceae (i.e. clovers, soybeans, and cohosh). Formononetin is known to be converted 
in the rumen (in sheep and cow) into a potent phytoestrogen, equol. Although, O-
demethylase, catalysing O-demethylation, has been attributed to metabolism by gut 
microflora, incubation of formononetin with human liver microsomes resulted in 4’-O-
demethylation to yield daidzein (Tolleson, et al. 2002) (Scheme 1).  
3.1.5 Biochanin A 
Biochanin A is an O-methylated isoflavone. Biochanin A can be found in red clover, soy, 
alfalfa sprouts, peanuts, chickpea and  other legumes. Biochanin A-containing supplements 
are derived from red clover and, in addition to biochanin A, usually contain genistein, 
daidzein and formononetin. In red clover, biochanin A exists as its glycoside (Fig. 3). 
However, the glycoside undergoes hydrolysis during extraction to form the aglycone (non-
sugar component). Biochanin A has weak estrogenic activities as measured in in vivo and in 
vitro assays. In comparison with other isoflavones, biochanin A is expected to have possible 
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anti-osteoporotic activity. Structurally, biochanin A would be expected to be able to 
scavenge reactive oxygen species and inhibit lipid peroxidation. In vitro and in vivo studies 
using rodents indicated that biochanin A has anticarcinogenic activity.  
 
 
Scheme 1. Biotransformation of formonetin, daidzein, and equol from ononin. 
3.1.6 Equol 
Equol has the 3S configuration and is produced by bacterial flora in the intestines as a 
metabolite of daidzein (Scheme 1). However, only about 30-50% of people have intestinal 
bacteria that produce equol. Equol is a non-steroidal estrogen that acts as an anti-androgen 
by blocking the hormone dihydrotestosterone. Equol has the ability to bind to ER. This 
may make equol advantageous in estrogen-related cancers, including breast cancer. Equol is 
unique because it not only has the ability to bind to ER, but also acts as an antagonist to 
androgen actions. Unlike anti-androgen drugs, equol does not bind to androgen receptors, 
but it binds directly to dihydrotestosterone. This mode of action has prompted studies to 
determine if men who are equol-producers may have an advantage against prostate cancer. 
3.1.7 Isoflavone glycosides 
Isoflavones generally exist as aglycones (Fig. 1) and their glycoside forms. Isoflavone 
glycosides isolated from soybeans are -glucosidated at C7-position of isoflavone core 
structure. Soybeans are known to contain daidzein, glycitin, 6”-acetylgenistin, 6”-
acetyldaizin (Waltz, 1931; Naim, et al. 1973; Ohta, et al. 1979). Later, malonylglycosides (6"-
O-malonyldaidzin, 6"-O-malonylgenistin, 6"-O-malonylglycitin) and succinylglycosides  (6"-
O-succinyldaidzin, 6"-O-succinylgenistin, 6"-O-succinylglycitin) are found in soybeans or 
soy products (Wang et al., 1994; Toda, 1999) (Fig. 3). Careful analyses of isoflavones in 
soybeans revealed that the malonyglycosides are the predominant isoflavones in soybeans. 
Mass balance of isoflavone glycosides vary depending on manufacturing process of soy 
products.  
As describe above, biological effects of aglycones of isoflavone glycosides found in soybeans 
have been of great interest in food science, food technology, nutrition and dietary 
supplements, and disease prevention or treatment. Due to the fact that isoflavones in 
soybeans are conjugated almost exclusively to sugars, thus, understanding of the 
mechanism of intestinal absorption of isoflavones in humans is an important subject. 
Evidence from intestinal perfusion and in vitro cell culture studies indicates that isoflavone 
glycosides are poorly absorbed, yet isoflavones are bioavailable and appear in high 
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concentrations in plasma, irrespective of whether they are ingested as aglycones or 
glycoside conjugates. Therefore, it was suggested that hydrolysis of the sugar moiety is an 
essential prerequisite for bioavailability of soy isoflavones (Setchell et al. 2002). 
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Fig. 3. Structures of soy isoflavone glycosides 
3.1.8 Controversial effect of soy isoflavones 
Recently, a lot of articles regarding the negative aspects of soy have been published. 
However, several controversy reports about the adverse effects are always not clear. This 
may be due to the lack of understanding of metabolism and bioavailability of isoflavones in 
soy products. Some studies concluded that the bioavailability and pharmacokinetics of 
isoflavones are significantly influenced by type of soy products. Examples of adverse effects 
of isoflavones are that genistein 1) increased the rate of proliferation of estrogen-dependent 
breast cancer in vitro when not co-treated with an estrogen antagonist, 2) decreased 
efficiency of tamoxifen and letrozole, drugs commonly used in breast cancer therapy, and 3) 
inhibited immune response towards cancer cells due in part to the reduction of thyroid 
function. In some analyses of current concerns regarding the estrogen-like effects of 
isoflavones in the breast cancers on the clinical trial data and recent evidence regarding 
estrogen therapy use in postmenopausal women, Messinia and Wood concluded that there 
is little clinical evidence to suggest that isoflavones will increase breast cancer risk in healthy 
women or worsen the prognosis of breast cancer patients. They also pointed out that the 
clinical trials often involved small numbers of subjects, and there is no evidence that 
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isoflavone intake increases breast tissue density in pre- or postmenopausal women or 
increases breast cell proliferation in postmenopausal women with or without a history of 
breast cancer. The Israeli health ministry has recommended only moderate consumption of 
soy products because of reported adverse effects of isoflavones (vide supra). On the other 
hand, the British Dietary Association concluded that evidence suggesting isoflavones reduce 
the symptoms of menopause is inconsistent. Although more clinical researches should be 
performed to definitively alleviate above concerns, the existing data should provide some 
degree of assurance that isoflavone exposure at levels consistent with a large amount of soy 
product intake does not result in adverse  effects on breast tissue (Messina et al, 2008). 
3.2 Phytic acid 
Phytic acid [hexakisphosphate (IP6)) or phytate] is present in the brans and hulls of most 
grains, beans, nuts, and seeds. Rich sources of phytic acid are wheat bran and flaxseed. 
Phytic acid is inositol hexaphosphate, and thus it is highly charged, which provided 
chelative (or binding) properties. Phytic acid binds to minerals and metals. Phytate is not 
digestible to humans or nonruminant animals. The chelated forms of phytic acid with Zn, 
Ca, and Mg make them impermeable molecules through cell membranes. Phytic acid blocks 
the body's uptake of essential minerals such as magnesium, calcium, iron and especially 
zinc. On the other hand, phytic acid is known to be an antioxidant as well as helpful in 
eradication of heavy metals and other toxic cation species from the body. 
 
 
Fig. 4. 
3.3 Soybean lipids 
Lipids are broadly defined as hydrophobic or amphiphilic molecules. Lipids include fatty 
acids, sterols, lipid-soluble vitamins (vitamins A, D, E and K), glycerolipids, phospholipids, 
glycolipids, and sphingoglycolipid. Soybeans contain 82% of triacylglycerol, 13% of 
phospholipids, about 1% of sterols, and 4% of unsaturated and saturated fatty acids in a 
total lipid extracted with chloroform-methanol (2/1). Phospholipid composition in a 
soybean lipid extract is phosphatidylcholine (42%), phosphatidylethanolamine (30%), 
phosphatidylinositol and phosphatidylserine (20%), lysophosphatidylcholine (1%), 
sphingomyeline (0.6%), phosphatidic acid and others, respectively (Takagi et al. 1985). 
Lipids remain an important research subject because of associations between consumption 
of lipids and the incidence of some chronic conditions including coronary artery disease, 
diabetes, cancer and obesity. Dietary lipids (or fats) serve multiple purposes. The 
importance of antioxidant ability of unsaturated fatty acids including -carotene in the 
prevention of cardiovascular disease as well as many cancers is being increasingly 
recognised. Although saturated fatty acids are generally considered cholesterolemic, it is 
now evident that the effect of some fatty acids on blood lipids and lipoproteins suggest that 
the major dietary fats containing in some food products (i.e. soybeans or palm oils) do not 
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raise plasma total fatty acids and LDL cholesterol levels. In recent times, adverse health 
concerns from the consumption of trans fatty acids arising from hydrogenation of oils and 
fats have been the subject of much discussion and controversy.  
 
 
Fig. 5. Structures of representative lipids isolated from soybeans   
3.3.1 Fatty acids and soybean oil 
Soybean oil is rich in polyunsaturated fatty acids, including the two essential fatty acids, 
linoleic and linolenic, that are not produced in the human body. Linoleic and linolenic acids 
aid the body's absorption of vital nutrients and are required for human health.  
In many applications, the higher saturate oils have been replaced with partially 
hydrogenated vegetable oils. Partially hydrogenated oils make the oil more stable and more 
resistant to air oxidation. Saturated fatty acids are more difficult to digest than unsaturated 
fatty acids and are seldom used for food product industry applications. Nature makes most 
mono- and polyunsaturated fatty acids in the cis form. However, during the partial 
hydrogenation process, the cis geometry of unsaturated fatty acids is partially isomerized to 
the trans form. Numerous research and epidemiological studies have been conducted to 
determine the impact of trans-fatty acids on cholesterol levels and coronary heart disease. 
The study by Troisi, et al. suggested a correlation between increased consumption of trans 
fatty acids and an increase in LDL (bad) cholesterol, which increases lipoprotein level and is 
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an independent risk factor for the development of coronary heart disease, and decrease in 
HDL (good) cholesterol. This could represent an increased risk of heart attacks by trans-fatty 
acid intake.  
 
 
Fig. 6. Structures of plant sterols from soybeans  
3.3.2 Soy sterol 
Soybeans contain plant sterols, -sitosterol, -sitostarol, campesterol, campestanol, 
brassicasterol, stigmasterol, and Δ5-avenasterol, and cholesterol (Fig. 6). Plant sterols are 
natural dietary components, and known to have serum cholesterol-lowering properties. The 
lowing of serum cholesterol by plant sterols is believed to be the result of an inhibition of 
cholesterol absorption in small intestine. Several studies suggested that unsaturated or 
saturated plant sterols showed different effects on cholesterol absorption and sterol 
excretion (Normén et al. 2007).  
3.3.3 Glycerolipids 
Glycerolipids are composed of mono-, di- and tri-substituted glycerols. In these compounds, 
the three hydroxy groups of glycerol are esterified (triacylglycerols) or one of hydroxy 
group forms the ether linkage. Subclasses of glycerolipids are represented by glycosyl 
glycerols and glycerophospholipids. Glycerophospholipids are subdivided into distinct 
classes which are characterized by the presence of one or more sugar or phosphate residues 
(i.e. phosphatidyl choline, phosphatidyl ethanolamine, phosphatidyl inositol, and 
phosphatidyl serine).  
Soybeans contain a wide variety of triacylglyceroles, however LC-MS analyses revealed that 
fatty acids incorporated in soy triacylglycerols are stearic acid, palmitic acid, oleic acid, 
linoleic acid, and linolenic acid (Neff et al. 1995). Fatty acids in soybeans are considered to 
be stored as triacylglycerides. 
Lecithin can easily be extracted from soybeans (or egg yolk) and soy lecithin is an additive 
found in many everyday foods (Fig. 5). It has low solubility in water. Due to its amphipathic 
characteristic, lecithin phospholipids can form either liposomes, bilayer sheets, micelles, or 
lamellar structures in aqueous solution. In cooking, it is sometimes used as an emulsifier 
and to prevent sticking (for example, in non-stick cooking spray) and or as a stabilizer in 
various food applications. Lecithin has been a popular supplement because it’s high choline 
(N,N,N-trimethylethanol) content. Choline is an essential nutrient that has benefit for heart 
health and brain development, as choline deficiency plays a role in liver disease, 
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atherosclerosis, and possibly neurological disorders. It is particularly important for pregnant 
women to get enough choline, since low choline intake may raise the rate of neural tube 
defects in infants, and may affect their child's memory. 
Phosphatidylinositol (PI) is classified as a glycerophospholipid that contains a glycerol 
backbone, two non-polar fatty acid tails, a phosphate group substituted with an inositol 
(myo-D-inositol in animals) polar head group. The most common fatty acids of PIs are stearic 
acid in the SN1 position and arachidonic acid in the SN2 position. Phosphatidylinositols play 
important roles in lipid signaling, cell signaling and membrane trafficking. The inositol ring 
can be phosphorylated by a variety of kinases.  
3.3.4 Cerebroside 
Sphingolipids are structural components of eukaryotic cell membranes. A large number of 
recent reports have indicated that sphingolipid are involved in a number of important 
regulatory processes in cell development. Cerebrosides (monoglycosylceramide) is the 
common name for a group of glycosphingolipids.  
Soya-cerebroside (Fig. 5) is a glucosylceramide isolated from soybeans, exhibited a Ca2+-
binding activity. The basic structure of soya-cerebroside II including the absolute 
stereochemistries of (2R)-hydroxy fatty acids are identical to one of the neural 
glucosylceramide. However, the main long-chain base (sphingosine moiety) is C18-4,8-
diunsaturated (E/Z). Biological functions of the cerebrosides in soybeans have not been 
thoroughly studied. Recently, a soya-cerebroside was reported to exhibit moderate 
tyrosinase inhibitory activity, and applied for making skin-care cosmetics for removal of 
(black) freckles. 
3.3.5 Sphingomyelin 
Sphingomyelin is a type of sphingolipid found in animal cell membranes, especially in the 
membranous myelin sheath that surrounds some nerve cell axons. It consists of 
phosphorylcholine and ceramide (Fig.5). In humans, sphingomyelin represents ~85% of all 
sphingolipids. On the other hand, only 0.6% of sphingomyelin was found in a total 
phospholipid isolated from soybeans (Takagi, et al. 1985). The accumulation of sphingomyelin 
(i.e. Niemann-Pick Disease) in brain causes irreversible neurological damage. Sphingomyelin 
in food products is not bioavailable, and thus the accumulation of sphingomyelin in human 
body is not considered possible by sphingomyelin containing food intake.  
3.3.6 Vitamin K 
Vitamin K is a lipid-soluble essential vitamin that is stable to air but susceptible to air under 
sunlight. The "K" is derived from the German word “koagulation”. Natural forms of vitamin 
K, vitamin K1 (phylloquinone) and vitamin K2 (menaquinone), exist in the human liver and 
other tissues at very low concentrations; vitamin K1 concentrates in the liver while vitamin 
K2 is well distributed to other tissues (Fig.6). Vitamin K1 is derived from dietary intake and 
vitamin K2 is produced by intestinal bacteria. Thus, vitamin K is not listed among the 
essential vitamins. Human get most of our dietary vitamin K in the form of phylloquinone 
(biosynthesized by plants). In prokaryotes, especially in Gram-positive bacteria, vitamin K2 
will transfer two electrons in a process of aerobic or anaerobic respiration (electron transport 
systems). Respiration occurs in the cell membrane of prokaryotic cells. Electron donors will 
,with the help of another enzyme, transfer two electrons to vitamin K2. Vitamin K2, with the 
help of another enzyme, will in turn transfer these two electrons to an electron acceptor.  
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Fig. 6. Structures of phylloquinone and menaquinone 
One tablespoon of soybean oil contains about 25 g of vitamin K1 (about 47 g of vitamin K1 
in 100g of soybeans). Green leafy vegetables and some vegetable oils are major contributors 
of dietary vitamin K. Nattō, a fermented Japanese soybean product, contains large amounts 
(approximately 870 g per 100 grams of nattō) of vitamin K2. Vitamin K2 is known to be 
more effective than vitamin K1 with respect to osteroclastogenesis, hypocholesterolemic 
effects, and ability to slow atherosclerotic progression. To date, no adverse effects have been 
reported for higher levels of vitamin K intake from food and/or supplements, there are no 
documented toxicity symptoms for vitamin K. 
3.3.7 Carotene 
In the human diet, carotenoids have been shown to have antioxidant activity which may 
help to prevent certain kinds of cancers, arthritis and atherosclerosis. -Carotene is a 
precursor of vitamin A (retinal) which is biosynthesized via the action of -carotene 15,15'-
monooxygenase. There are nearly 600 carotenoids in nature. In humans, four carotenoids (-
carotene, -carotene, -carotene, and -cryptoxanthin) have vitamin A activity, and they can 
be converted to retinal. Mature soybean seeds contain about 1 g of carotenoids. However, 
concentrations of carotenoids are increased several fold during germination. Due to 
versatility of soybeans in use, genetic modification of soybeans is a popular subject. 
Genetically engineered soybean can now produce -carotene 1,400-fold over non-trasngenic 
soybeans.  
3.3.8 Vitamin E 
Vitamin E is a lipid-soluble compound and a family of eight related compounds that 
includes both tocopherols and tocotrienols. -Tocopherol is most abundant in foods and 
also dominates in vitamin E supplements; the other leading types are -, -, and -
tocopherol. -Tocopherol has become synonymous with vitamin E, and vitamin E is one of 
the most popular supplements. Vitamin E has antioxidant activities that stop the production 
of reactive oxygen species formed when unsaturated fatty acids undergo oxidations. 
Soybeans and corns contain -tocopherol (about 12.0 mg of -tocopherol in 100g of total soy 
lipids) (Fig. 5), while -tocopherol is found in olive oil. In vitro experiments, -tocopherol 
killed animal cells at high concentrations, but -tocopherol did not show cytotoxicities at the 
same concentrations. Interestingly, although people in the United State tend to use corn and 
soybean oil for cooking, most abundant in the body is -tocopherol. Other than antioxidant 
activities, ǂ-tocopherol is reported to inhibit protein kinase C activity, which is involved in 
cell proliferation and differentiation. Vitamin E inhibits platelet aggregation and enhances 
vasodilation. Vitamin E enrichment of endothelial cells downregulates the expression of cell 
adhesion molecules, thus decreasing the adhesion of blood cell components to the 
endothelium. 
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Scheme 2. Synthesis of ergocalciferol from ergosterol (vitamin D2) 
3.3.9 Vitamin D2 (Ergocalciferol) 
There are only a few food sources (fish, liver, and egg yolk) of vitamin D. These are many 
fortified foods (i.e. milk, soy drinks, orange juice and margarine) that contain vitamin D. 
Ergosterol, called provitamin D2, is found in ergot, yeast, and other fungi. It is converted to 
vitamin D2 (ergocalciferol) upon irradiation by ultraviolet (UV) light or electronic 
bombardment (Scheme 2), whereas, vitamin D3 (cholecalciferol) is normally synthesized in 
the human skin from 7-dehydrocholesterol. Vitamins D2 and D3 are about equal in activity 
in all mammals (some literatures described that vitamin D3 is slightly less bioactive). 
Deficiency of vitamin D can result in rickets (a softening of bones) in children and 
osteomalacia in adults. The relationship between ergosterol content in soybeans or soybean 
oils and soybean fungi was studied. For an example, in the studies of soybeans inoculated 
with spores of Aspergillus ruber, ergosterol concentrations in seeds increased with time of 
storage (Dhingra, et al. 1998). 
 
 
 
Fig. 7. Representative structures of soy phytoalexins 
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3.4 Soy phytoalexins  
Phytoalexins are antimicrobial substances synthesized by plants that accumulate rapidly at 
areas of pathogen infection. They are, in general, broad spectrum inhibitors and structurally 
diverse molecules have been isolated from different plant species. Phytoalexins are known 
to inhibit bacterial or fungus cell wall biosynthesis, or delay maturation, or disrupt 
metabolism. To date, several soy phytoalexins have been reported. 6a-Hydroxyphaseollin 
was the first structurally defined phytoalexin isolated from fungal infected soybeans. 
Several other hydroxypterocarpan (benzopyrano-furanobenzenes) derivatives are 
biosynthesized as phytoalexins by soybean tissues on treatment with a variety of biotic or 
abiotic agents. Glyceollins are a family of pterocarpan found in the Fabaceae family 
including activated soy. They are biosynthesized from the isoflavone, daidzein (Fig. 1) via 2'-
hydroxyisoflavone reductase as illustrated in Scheme 3. The concentration of phytoalexins 
in soybeans is very low since the compounds are only produced by soy as a defence 
mechanism from disease or infection. For an example, the accumulation of glyceollins in 
soybean cotyledon tissue was observed using four species of Aspergillus; 955 μg/g of 
glyceollins could be isolated from soybean cotyledon tissue inoculated with A. sojae. 
Representative phytoalexins identified from fungal infected soybeans are summarized in 
Fig. 7. Besides their antifungal or antibacterial activities, glyceollins have recently been 
demonstrated to be novel antiestrogens that bind to the estrogen receptor (ER) and inhibit 
estrogen-induced tumor progression (Zimmermann et al. 2010). Therefore, glyceollins may 
represent an important component of a phytoalexin-enriched food diet in terms of 
chemoprevention as well as a novel therapeutic agent for hormone-dependent tumors. 
 
 
Scheme 3. Biosynthesis of glyceollins 
3.5 Coumestrol  
Coumestrol is classically categorized as phytoestrogens because this molecule binds to the 
estrogen receptor (ER). Coumesterol is originally isolated from alfalfa (Bikoff et al. 1957), but 
later soybeans and clover contain the highest concentrations of this molecule. Biosynthesis 
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of coumestrol in soy is proposed based on the feeding experiments of labeled precursors to a 
coumestrol producing bacteria (Berlin et al. 1972). As illustrated in Scheme 4, the isoflavone, 
daidzein is reduced to form 2’-hydroxy-2,3-dihydrodaidzein which undergoes 
intramolecular condensation to yield 3,9-dihydroxypterocarp-6a-en. Biological oxidation of 
the dihydroxypterocarpen furnishes coumestrol.  
 
 
Scheme 4. Biosynthesis of coumestrol 
Coumestrol has less estrogen activities than estrogen and therefore may reduce the risk of 
developing breast or prostate cancer in humans by preventing estradiol binding to estrogen 
receptor (ER). Coumestrol was reported to inhibit the enzymes involved in the biosynthesis 
of steroid hormone (aromatase and hydroxysteroid dehydrogenase), and inhibition of these 
enzymes results in the modulation of hormone production. 
 
 
Fig. 8. Representative structures of soyasaponins  
3.6 Soyasaponins  
Saponins are amphipathic glycosides grouped phenomenologically by the formation of 
soap-like froth when shaken in aqueous solutions. Structurally, saponins contain one or 
more glycoside moieties combined with a lipophilic triterpene derivative. Many health 
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benefits of soybeans are believed to be attributed to their Saponins. Many soy products 
contain high levels of saponins. Raw soybeans contain between 2 and 5 g saponins per 100 g. 
Soy saponins are divided in two groups; group A saponins have and undesirable astringent 
taste, and group B saponins have the health promoting properties.  
The blood cholesterol-lowering properties of dietary saponins are of particular interest in 
human nutrition. Saponins bind cholesterol and bile acids in the gut. Cancer cells have more 
cholesterol-type compounds in their membranes than normal cells. Soy saponins can bind 
cholesterol in vitro, and thus interfere with cell growth and division. Soy saponins also 
showed antifungal activities probably due to interference with cholesterol in fungus. 
Saponins cannot permeate the intestinal wall, but showed effectiveness in binding to 
cholesterol and making it unavailable for re-absorption within the small and large intestine. 
Apart from their important role in binding ability to cholesterol, soy saponins showed 
adjuvant effects for vaccines. An in vitro study demonstrated that soy saponins exhibited 
potent antiviral effects on the HIV virus. To date, over 26 soyasaponins have been isolated 
from soybeans and their gross structures were determined via high-magnetic field NMR or 
X-ray crystallography. Representative soyasaponins are illustrated in Fig. 8. 
3.7 Lectins and hemagglutinins  
Lectins are plant derived proteins which are capable of binding to carbohydrate moieties of 
complex glycoconjugates but do not possess immunoglobulin nature. They typically 
agglutinate certain animal cells and/or precipitate glycoconjugates. Many members of the 
lectinic protein family agglutinate red blood cells. This particular nature of lectinic proteins 
is classified into hemagglutinin. Lectins are stable proteins that do not degrade easily. For 
examples, some lectins are resistant to stomach acid and digestive enzymes. Unfermented 
soy products contain high levels of lectins/hemagglutinins. Hemagglutinin renders red 
blood cells unable to absorb oxygen. However, the soybean fermentation process deactivates 
soya hemagglutinins, and thus the amounts of lectins present in soybeans have not been 
considered to be as potentially toxic components. On the other hand, some dried bean 
products may still contain a large amount of active lectins. These lectins are believed to 
trigger allergic reactions or toxic reactions in a person’s body. Person’s lectin sensitivity is 
largely due to 1) genetics, 2) a failure of mucosal immunity (secretory IgA), and 3) bacterial 
or viral infections that damage human cells, making human body susceeptable to lectin 
antibody/antigen reactions.   
 
 
Fig. 9. Water soluble vitamins isolated from soy  
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3.8 Soy toxins 
Soy contains several naturally occurring compounds that are toxic to humans and animals. 
The best known of the soy toxins is the trypsin (a serine protease found in the digestive 
system) inhibitors. In vivo studies using rat, high levels of exposure to trypsin inhibitors 
isolated from raw soy flour cause pancreatic cancer whereas moderate levels cause the rat 
pancreas to be more susceptible to cancer-causing agents. However, the US FDA concluded 
that low levels of soy protease inhibitors pose no threat to human health. Recently, a 
metalloprotein possessing toxicity to mice (LD50 7-8 mg/kg mouse upon intraperitoneal 
injection) was identified. This protein has a size of 21 kDa and was named soyatoxin. Some 
other biological properties of soyatoxin include hemagglutination and trypsin inhibitory 
activity. 
3.9 Water-soluble vitamins 
Soybeans are not considered to be very rich sources of any particular vitamin, but they 
contain a wide variety of vitamins and do contribute to an overall nutritional well-being. 
Lipid-soluble vitamins (vitamin K, E, D and carotene) in soybeans are discussed above. The 
water-soluble vitamins in soybeans are thiamine, riboflavin, niacin, pantothenic acid, biotin, 
folic acid, inositol, choline, and vitamin C. Vitamin B6 was also reported to contain in 
soybeans. Thus, soy includes essential vitamins except for vitamin B12 and E. However, soy 
contains a vitamin E precursor, carotene. Numerous studies have been conducted over the 
past decades on the relative distribution and concentrations of these vitamins in different 
portion of soy. The cotyledons contain notably greater amount of all water soluble soy 
vitamins than those in the hypocotyl. The quantity of all vitamins except thiamine increases 
through germination (Wai et al., 1947).   
4. Conclusion  
This chapter summarizes structures of biological active molecules isolated from soy, and 
their biological activities are briefly reviewed. Since the discovery of soybeans as rich source 
of protein and oil in 1904, a numerous number of experimental data have been accumulated 
on chemistry and biochemistry of phytochemicals isolated from soy and soy products. To 
date, a wide variety of organic compounds have been characterized from soy. The interest of 
structure elucidation studies of bioactive molecules in soy was to obtain insight into 
correlation between the reported health benefits, which are associated with soy intake, and 
soy phytochemicals. Thus, many structural studies on soy have not aimed to discover novel 
molecules, albeit these efforts resulted in discovery of complex soyasaponins (Fig. 8.). The 
consumption of soy products has many health benefits, including protection against breast 
cancer, prostate cancer, menopausal symptoms, heart disease and osteoporosis. These health 
benefits of soy are believed to be due in part to phytoestrogenic activity of isoflavones, 
which are stored as glucosyl- and malonyl-glucose conjugates in soybeans. Isoflavon-
glucosyl conjugates show very poor oral bioavailability. Recently, the negative aspects of 
soy have been reported (3.1.8). However, the controversy reports about the adverse effects 
of soy are not clear. This may be due to the lack of understanding of metabolism and 
bioavailability of isoflavone-glucosyl conjugates in soy. Some researchers concluded that 
there is little clinical evidence to suggest that isoflavones will cause the adverse effects (e.g. 
breast cancer risk in healthy women). It is important to note that all phytochemicals isolated 
from soy show an array of weak biological activities, and thus, normal consumption of 
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foods that contain these phytochemicals should not provide sufficient amounts to elicit a 
visible physiological response in humans in short-time clinical researches.  
Unfermented soy products contain high levels of lectins/hemagglutinins, and very low level 
of soy toxins (protease inhibitors). Most of these proteins will be deactivated through food 
processing. Remarkably, seeds of soy contain very high levels of protein, carbohydrate 
conjugates, oil, and minerals. On the other hand, remaining components discussed in this 
chapter can be isolated minute quantities from soybeans, however, a wide range of health 
benefit of soy phytochemicals (lipids, phytoestrogens, soy sterols, vitamins, soyasaponins) 
contributes to the overall nutritional well-being of humans. 
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